Skip to main content

Table 1 Demographic characteristics and risk factors for retained placenta

From: Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial

Characters and risk factors

Groups(n = 23, in each group)

Mean ± SD

P

Age (years)

Mesoprostol group

24.52 ± 5.169

*.374

Normal saline group

25.83 ± 4.668

Parity

Mesoprostol group

1.30 ± 1.222

*.37

Normal saline group

2.00 ± 0.953

G. age (weeks)

Mesoprostol group

37.22 ± 2.876

*.559

Normal saline group

37.61 ± 1.373

History of dilatation and curettage

Mesoprostol group

4(17.4%)

**1.000

Normal saline group

5(21.7%)

History of preterm labour

Mesoprostol group

4(17.4%)

**0.347

Normal saline group

1(4.3%)

History of retained placenta

Mesoprostol group

1(4.3%)

**1.00

Normal saline group

0(0%)

  1. *T-Test, **χ 2 test.